language_icon
EN
HI

Aster DM Healthcare Share price

ASTERDM

685.35

1.05 (0.15%)
NSE
BSE
Last updated on 23 Apr, 2026 | 13:36 IST
Today's High

692.95

Today's Low

681.85

52 Week Low

492.20

52 Week High

732.20

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aster DM Healthcare Chart

Aster DM Healthcare Share Key Metrics

Volume
5.21 L
Market Cap
35455.02 CR
LTQ@LTP
14@685.35
ATP
685.97
Var Margin
16.33 %
Circuit Range
547.45-821.15
Delivery %
62.8 %
Value
35.71 CR
ASM/GSM
No
Market Lot
1

Summary

23 Apr, 2026 | 13:36 को, Aster DM Healthcare का शेयर प्राइस आज ₹685.35 पर है, जो दिन के लिए 1.05% की 0.15 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹681.85 और ₹692.95 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹492.20 से ₹732.20 तक रही है। ट्रेडिंग गतिविधि के मामले में, Aster DM Healthcare ने 520632 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹518121029 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹68597 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 14,68535 रही। यह स्टॉक ₹547.45-821.15 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹35.71 CR है। दिन के लिए डिलीवरी परसेंटेज 62.8% रही। इसके अतिरिक्त, Aster DM Healthcare वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Aster DM Healthcare Fundamentals

View More
P/E Ratio

108.44

P/B Ratio

7.71

Div. Yield

17.97

Sector P/E

54.04

Sector P/B

-16.13

Sec. Div. Yield

2.25

Aster DM Healthcare Resistance and Support

Pivot 681.15

Resistance

First Resistance

689.05

Second Resistance

693.8

Third Resistance

701.7

Support

First Support

676.4

Second Support

668.5

Third Support

663.75

Aster DM Healthcare Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

40.39%

Mutual Fund

26.45%

Insurance

0.67%

Foreign Institutional Investors

17.18%

Domestic Institutional Investors

0.45%

Retail

14.85%

Others

0.01%

Total Promoters
MAR '26
40.39%

Aster DM Healthcare Corporate Actions

DateAgenda
2026-03-26Interim Dividend
2026-01-30Quarterly Results & ESOP

Aster DM Healthcare News

Aster DM Healthcare Limited

Aster DM Healthcare disclosed its Q4 FY26 shareholding pattern. The promoter and promoter group hold 40.39% of the shares, with 40.66% of their holding encumbered by pledge. Public shareholders account for 59.38% of the company.
Apr 21 2026 17:04:00

Aster DM Healthcare Ltd - 540975 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Aster DM Healthcare shareholders approved Dr. Mandayapurath Azad Moopen's appointment as Executive Director and the resolution for granting loans/guarantees under Section 185 of the Companies Act, 2013, via postal ballot completed on April 12, 2026.
Apr 15 2026 19:04:00

Aster DM Healthcare Limited

Aster DM Healthcare informed that all resolutions in the postal ballot have been duly passed by members with the requisite majority on April 12, 2026. This includes the appointment of Dr. Mandayapurath Azad Moopen as Executive Director and approval for granting loans/guarantees.
Apr 15 2026 19:04:00

Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

Aster DM Healthcare resolves nurse strike in Kerala hospitals, with all staff returning to work and operations resuming full capacity. The company incurred a revenue loss of ₹5.77 crore due to the strike and activated internal contingency measures during the period.
Apr 15 2026 12:04:00

Aster DM Healthcare Limited

Aster DM Healthcare's nurse staff in Kerala have resumed full operations following a strike. The company incurred an additional revenue loss of ₹5.77 crore due to the disruption, though no further revenue loss is anticipated under current conditions while legal proceedings continue.
Apr 15 2026 12:04:00

Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aster DM Healthcare invested ₹96 crore to expand its Women & Children facility at Aster Whitefield Hospital, Bengaluru. This increases bed capacity from 380 to 539 beds, enhancing specialized maternal and pediatric care.
Apr 13 2026 10:04:00

Aster DM Healthcare Limited

Aster DM Healthcare invested ₹96 crore to expand its Women & Children facility at Aster Whitefield Hospital, Bengaluru. This increases bed capacity from 380 to 539, significantly strengthening its regional healthcare footprint.
Apr 13 2026 10:04:00

Aster DM Healthcare Limited

Aster DM Healthcare invested ₹96 crore to expand its Women & Children facility at Aster Whitefield Hospital, Bengaluru. This increases bed capacity from 380 to 539, significantly strengthening its regional healthcare footprint.
Apr 13 2026 10:04:00

Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Aster DM Healthcare published newspaper advertisements regarding its scheme of amalgamation with Quality Care India Limited. The NCLT hearing for the joint company petition is scheduled for May 22, 2026, as per the public notice.
Apr 02 2026 16:04:00

Aster DM Healthcare Limited

Aster DM Healthcare's amalgamation scheme with Quality Care India Limited is set for an NCLT hearing on May 22, 2026. The joint petition seeks approval from both companies' shareholders and creditors, with the initial filing made on March 23, 2026.
Apr 02 2026 16:04:00
Read More

About Aster DM Healthcare AboutThe

NSE : 1508  
BSE : 540975  
ISIN : INE914M01019  

The Company was incorporated as DM Healthcare Private Limited on January 18 2008 at Kochi Ernakulam Kerala India as a private limited company under the Companies Act 1956. The name of the Company was changed to Aster DM Healthcare Private Limited and a fresh certificate of incorporation consequent upon change of name was issued on November 29 2013. The name of the Company was changed from DM Healthcare Private Limited to Aster DM Healthcare Private Limited to align theselves with the brand name ‘Aster’ and leverage the value of the brand.Major events and milestones of the Company1987- The Promoter Dr. Azad Moopen started a clinic in Dubai1995- The first specialty medical centre was launched in Dubai2001- MIMS Kozhikode Hospital commenced operations2005- Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations2006- Medcare Hospital commenced operations2008- India Value Fund III A acquired 28.20% of the paid up Equity Share capital the Company calculated at the time ofinvestment- The Company acquired majority stake in PHL Kolhapur2009- Al Raffah Hospital the first hospital in Oman commenced operations in Muscat2010- The Company acquired 100% of the paid up equity share capital of Affinity Mauritius- Al Raffah Hospital the second hospital in Oman commenced operations in Sohar2011- Second Medcare Hospital namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations2012- Olympus acquired 25.47 % of the paid up equity share capital of the Company- 40.80% of the paid up equity share capital of Sanad Al Rahma for Medical Care LLC was conditionally acquired2013- The Company acquired 60.35% of the paid up equity share capital of IHPL and consequently MIMS became the Subsidiary.2014- The Company acquired hospital operational and management rights in Aster CMC Bangalore pursuant to the hospital operation and management agreement dated May 12 2014- Aster Medcity was inaugurated in Kochi Kerala- The Company acquired 51% voting rights in Sainatha Hospitals Andhra Pradesh- We acquired 54% stake in Aster Kuwait- We acquired 51% stake in Orange Pharmacies LLC Jordan2015- First clinic in the Kingdom of Bahrain commenced operations- First clinic in the Philippines commenced operations2016- The Company divested its stake in Medipoint Hospitals Private Limited Pune- The Company acquired hospital operational and management rights in DM Wayanad Institute of Medical Sciences Wayanad pursuant to a medical services agreement and an operation and management agreement both dated March 4 2016- The Company increased stake up to 70.68% in the paid up equity share capital of MIMS- We increased stake up to 97% stake in Sanad Medical Care- Acquisition of 51% stake in Dr Ramesh Hospital- The second clinic in Bahrain commences operations- Medcare Women and Child Hospital in Dubai was launched- Launch of the first multi-specialty hospital in Sharjah2017- Entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru- Medare Hospital Sharjah commenced operations- Aster Hospital Doha commenced operations Awards and Accreditations 2001- MIMS Hospital Kozhikode India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control. MIMS subsequently received this certificate of merit in 2007 2008 2009 2010 2011 2012 and 2013 for various hospitals2006- MIMS Hospital Kozhikode India received NABH accreditation valid upto October 29 2009 which was subsequently renewed up to October 29 20182012- MIMS Laboratory Services MIMS received ISO 15189:2007 certification in the field of Medical Testing valid up to October 8 2016 which was subsequently renewed as ISO 15189:2012 up to October 8 20182013- Medcare Hospital LLC Dubai UAE received JCI accreditation valid up to December 21 2016 which was subsequently renewed up to November 10 2019- Medcare Orthopaedics and Spine Hospital Dubai UAE received JCI accreditation valid up to December 19 2016 which was subsequently renewed up to November 16 20192014- Aster Pharmacy Group received the Best Service Performance Brand Award by Dubai Service Excellence Scheme2015- Aster Medcity Kochi India received NABH accreditation for compliance with the Certification Standards for Nursing Excellence valid up to March 30 2017 which was subsequently renewed up to March 30 2019- Aster Medcity Kochi India received NABH accreditation valid up to March 30 2018- Aster Medcity Kochi India received the ISO 22000:2005 certification for production and service of food for patients staff and patients’ relatives within the hospital from Bureau Veritas Certification Holding SAS – UK Branch valid up to July 16 2018- Aster Pharmacies Group LLC has been awarded ‘Superbrand’ status by the UAE Superbrands Council- Aster Medcity Kochi India received JCI accreditation valid up to June 19 2018- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Dialysis Service Provider’ by CMO Asia- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign – Healthcare Industry’ by CMO Asia- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Healthcare Entreprenuer’ by CMO Asia- Dr. Ramesh Hospital (Labbipet branch) received NABH – entry level accreditation which is valid up to September 25 2019- Aster Aadhar Hospital Pune Maharashtra received NABH accreditation which is valid up to June 3 2018- Aster Jubilee Medical Complex Dubai received JCI accreditation which is valid up to September 3 2018- Al Raffah Hospital Sohar received JCI accreditation which is valid up to August 26 20182016- The Company received the ‘Institutional Bravery Award’ for Distinguished Service in Flood Relief in Chennai and Cuddalore 2015 by the Society for Emergency Medicine India- Aster Hospital Mankhool Dubai received JCI accreditation which is valid up to June 2 2019- Aster Medcity Kochi India received the ‘Quality Beyond Accreditation Award’ by the Association of Healthcare Providers (India)- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Healthcare Entreprenuer’ by CMO Asia- Aster Medcity Kochi India received the ‘Dhanam Award 2016 - NRK Brand of the Year’ award- Aster Medcity Kochi India received the ‘Distinction in Quality of Service Delivery Award’ by Asia Healthcare- Aster Medcity Kochi India received the ‘Nursing Excellence Award’ by the Association of Healthcare Providers (India)- Aster Medcity Kochi India received the ‘Award for Best Quality Initiative in Healthcare’ by Asia Healthcare- The Company received the ‘Award for the Best Marketing Campaign’ by Asia Healthcare- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign’ by CMO Asia- Aster Medcity Kochi India received the Certificate of Honor from the NABH for being ‘One of the Best & Safest Hospitals in India’- Aster Medcity Kochi India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control- The Clinical Laboratory Services at Dr. Ramesh Hospital received NABL accreditation for medical testing in the disciplines of clinical biochemistry clinical pathology haematology and immunohaematology which is valid up to July 24 2018- The Clinical Laboratory Services at Dr. Ramesh Hospital received NABL accreditation in medical testing which is valid up to September 5 2018- Dr. Ramesh Hospital (Guntur branch) has received NABH accreditation which is valid up to September 26 2019- We received the “Qadat Al Tagheer Award 2016” for Excellence in Healthcare Sector- We received the Frost and Sullivan ME growth award for Health Awareness Campaign of the Year UAE (2016)- Aster Pharmacies Group received the Dubai Quality Appreciation Award for 2016 from the Government of Dubai- Aster Pharmacy received the Best Service Performance Brand Award by Dubai Service Excellence Scheme2017- Aster CMI hospital received the ‘Best Hospitality in Healthcare’ award from the Times Network- Aster CMI hospital has been ranked as the 23rd best multi specialty hospital (national rankings) 7th best multi specialty hospital (South India) and 2nd best multi specialty hospital in Bangalore in the All India Multispecialty Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 12th in cardiac sciences (national rankings) 3rd in cardiac sciences (South India) and 2nd in cardiac sciences in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 6th in nephrology (South India) and 3rd in nephrology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 11th in gastroenterology and hepatology (South India) and 3rd in gastroenterology and hepatology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 4th in neuro sciences Bangalore and 4th in urology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has received the ‘CMO Asia Presents Asia Healthcare Excellence Award’ in the ‘best hospitality in healthcare’ category- Dr. Ramesh Hospital has received the Healthcare Excellence Award 2017 for Patient Centricity from FICCI

Read More

Aster DM Healthcare Management

NamePosition
Azad MoopenChairman & Managing Director
Alisha MoopenDeputy Managing Director
View More

Aster DM Healthcare FAQs

Aster DM Healthcare शेयर का खरीद मूल्य 685.35 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Aster DM Healthcare शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Aster DM Healthcare शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 108.44 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Aster DM Healthcare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 7.71 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aster DM Healthcare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो -16.13 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aster DM Healthcare का मार्केट कैप 35455.02 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Aster DM Healthcare शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 732.20 और 492.20 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost